Tempest Therapeutics, Inc. (TPST) income statement
TPSTNasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.31−0.00 (-1.10%)
Close on Nov 19, 2026Market cap $4.53MP/E –Yield –
Tempest Therapeutics, Inc. financial ratios
See a number that looks wrong?